Stock Taper 
SILVERARC CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Veracyte, Inc. | VCYT | 318K | $18.68M |
 Rhythm Pharmaceuticals, Inc. | RYTM | 311.46K | $34.58M |
 Ascendis Pharma A/S | ASND | 206.23K | $55.01M |
 Xenon Pharmaceuticals Inc. | XENE | 186.82K | $11.28M |
 Abivax S.A. | ABVX | 169.59K | $22.6M |
 Vaxcyte, Inc. | PCVX | 145K | $8.43M |
 GeneDx Holdings Corp. | WGS | 122.27K | $8.39M |
 Alkermes plc | ALKS | 113.49K | $5.95M |
 uniQure N.V. | QURE | 105K | $4.84M |
 Guardant Health, Inc. | GH | 99.83K | $14.98M |
 Veradermics, Incorporated | MANE | 95K | $11.68M |
 Disc Medicine, Inc. | IRON | 82.8K | $6.06M |
 Praxis Precision Medicines, Inc. | PRAX | 65.68K | $21.99M |
 Spyre Therapeutics, Inc. | SYRE | 59.96K | $5.32M |
 Biogen Inc. | BIIB | 48.1K | $10.39M |
 Insmed Incorporated | INSM | 34.44K | $3.67M |
 Revolution Medicines, Inc. | RVMD | 10K | $1.87M |